SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-24-016797
Filing Date
2024-04-29
Accepted
2024-04-26 21:22:48
Documents
17
Period of Report
2024-02-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 52029
2 ex99-1.htm EX-99.1 218220
3 ex99-2.htm EX-99.2 145154
4 ex99-3.htm EX-99.3 186510
  Complete submission text file 0001493152-24-016797.txt   904823

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lgst-20240214.xsd EX-101.SCH 3815
6 XBRL DEFINITION FILE lgst-20240214_def.xml EX-101.DEF 26691
7 XBRL LABEL FILE lgst-20240214_lab.xml EX-101.LAB 36844
8 XBRL PRESENTATION FILE lgst-20240214_pre.xml EX-101.PRE 25315
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 6053
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41002 | Film No.: 24886228
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)